Back to Search Start Over

Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction : A Report From the Swedish Coronary Angiography and Angioplasty Registry

Authors :
Redfors, Björn
Jha, Sandeep
Thorleifsson, Sigurdur
Jernberg, Tomas
Angerås, Oskar
Frobert, Ole
Petursson, Petur
Tornvall, Per
Sarno, Giovanna
Ekenbäck, Christina
Ravn-Fisher, Annika
Y-Hassan, Shams
Lyon, Alexander R.
James, Stefan
Erlinge, David
Omerovic, Elmir
Redfors, Björn
Jha, Sandeep
Thorleifsson, Sigurdur
Jernberg, Tomas
Angerås, Oskar
Frobert, Ole
Petursson, Petur
Tornvall, Per
Sarno, Giovanna
Ekenbäck, Christina
Ravn-Fisher, Annika
Y-Hassan, Shams
Lyon, Alexander R.
James, Stefan
Erlinge, David
Omerovic, Elmir
Publication Year :
2021

Abstract

Background: Takotsubo syndrome (TS) is a potentially life-threatening acute cardiac syndrome with a clinical presentation similar to myocardial infarction and for which the natural history, management, and outcome remain incompletely understood. Our aim was to assess the relative short-term mortality risk of TS, ST-segment-elevation myocardial infarction (STEMI), and non-STEMI (NSTEMI) and to identify predictors of in-hospital complications and poor prognosis in patients with TS. Methods and Results: This is an observational cohort study based on the data from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). We included all patients (n=117 720) who underwent coronary angiography in Sweden attributed to TS (N=2898 [2.5%]), STEMI (N=48 493 [41.2%]), or NSTEMI (N=66 329 [56.3%]) between January 2009 and February 2018. We compared patients with TS to those with NSTEMI or STEMI. The primary end point was all-cause mortality at 30 days. Secondary outcomes were acute heart failure (Killip Class >= 2) and cardiogenic shock (Killip Class 4) at the time of angiography. Patients with TS were more often women compared with patients with STEMI or NSTEMI. TS was associated with unadjusted and adjusted 30-day mortality risks lower than STEMI (adjusted hazard ratio [adjHR], 0.60; 95% CI, 0.48-0.76; P<0.001), but higher than NSTEMI (adjHR, 2.70; 95% CI, 2.14-3.41; P<0.001). Compared with STEMI, TS was associated with a similar risk of acute heart failure (adjHR, 1.26; 95% CI, 0.91-1.76; P=0.16) but a lower risk of cardiogenic shock (adjHR, 0.55; 95% CI, 0.34-0.89; P=0.02). The relative 30-day mortality risk for TS versus STEMI and NSTEMI was higher for smokers than nonsmokers (adjusted P interaction STEMI=0.01 and P interaction NSTEMI=0.01). Conclusions: The 30-day mortality rate in TS was higher than in NSTEMI but lower than STEMI despite a similar risk of acute heart failure in TS and STEMI. Among patients with TS, smoking was an independent predictor of

Details

Database :
OAIster
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1280666143
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1161.JAHA.119.017290